If you have read anything about medical cannabis, you have probably come across the endocannabinoid system. What most articles leave out is that this system behaves differently across the female reproductive lifespan and that hormones, particularly estrogen, are closely involved in how it works.
That is not a marketing angle. It is a mechanism, and it is the reason a growing number of Canadian women are asking their practitioners about cannabinoids for symptoms that have not responded to anything else.
What the endocannabinoid system actually is
The endocannabinoid system, or ECS, is a signalling network that runs throughout the body. It has three parts: cannabinoids your body makes itself, receptors those cannabinoids act on, and enzymes that build and break them down. Its broad job is regulation helping keep processes like pain signalling, mood, sleep, appetite, temperature and immune response within a workable range.
The two best-studied cannabinoids the body produces are anandamide and 2-AG. The two best-known receptors are CB1, concentrated in the nervous system, and CB2, more associated with immune tissue. Plant cannabinoids interact with this same system, which is why they can influence such a wide range of symptoms. If you are new to the individual compounds, our guides to what CBD is, what CBG is and the differences between THC and CBD cover the basics.
Where female physiology comes in
The ECS is notably active in female reproductive tissue. Reviews of the research describe endocannabinoid signalling as a significant factor in ovarian function and across reproductive processes generally.
Two points matter most for patients:
- Anandamide levels are not static across the month. They shift across the menstrual cycle, running higher in the follicular phase and around ovulation, and lower in the luteal phase.
- Estrogen helps regulate the enzyme that breaks anandamide down. Estrogen influences FAAH fatty acid amide hydrolase which controls how quickly anandamide is cleared. When estrogen keeps FAAH activity low, anandamide stays higher for longer.
The practical implication is straightforward. If estrogen helps regulate the system, then anything that changes estrogen levels the monthly cycle, perimenopause, menopause also affects how efficiently the system runs. Researchers reviewing menopause specifically have described how reduced hormone levels after menopause may alter cannabinoid receptor expression and endocannabinoid levels, and with them the efficiency of receptor signalling.
Why this shows up in real symptoms
The symptoms that bring women to a medical cannabis consultation are rarely random. Pain, disrupted sleep, anxiety and mood changes are all processes the ECS is and all of them are common at exactly the points in life when hormone levels are shifting most.
That does not mean cannabis fixes them. It means there is a plausible mechanism behind why so many women report that it helps. Different cannabinoids are associated with different effects, which our comparison of CBN, CBD and CBG for sleep, pain and mental health explains in more detail.
What the evidence does and does not support
This is where honesty matters more than enthusiasm.
The mechanistic research how the ECS interacts with estrogen and reproductive tissue is reasonably well established. The clinical research is much thinner. For most women’s health conditions, what exists is survey data, patient-reported outcomes and observational studies rather than large randomised controlled trials.
That is a real limitation, and any clinic that tells you otherwise is overstating its case. What it means in practice is that medical cannabis is worth discussing as an option, particularly where conventional treatment has not worked, but it should be approached as a supervised trial with realistic expectations rather than a guaranteed solution.
An important safety point
Canadian obstetric guidance is clear that cannabis should be avoided during pregnancy and while breastfeeding, and that it should not be used for nausea and vomiting in pregnancy. If you are pregnant, trying to conceive, or breastfeeding, this is a conversation to have with your healthcare provider before anything else.
How access works in Canada
Medical cannabis in Canada requires authorisation from a healthcare practitioner. Our complete guide to getting a cannabis prescription in Canada walks through eligibility and what to expect, and the step-by-step guide to the prescription process covers the practical sequence. If you would prefer to grow your own supply, the ACMPR licence guide explains how personal production works.
Cost is a common barrier. A number of programs and plans cover medical cannabis — see our eligible for coverage page and the article on whether your health insurance covers medical cannabis. Ongoing clinical support is available through primary care.
Frequently asked questions
Does the endocannabinoid system work differently in women than in men?
The system itself is the same, but its activity is closely linked to reproductive hormones, and estrogen helps regulate one of the key enzymes involved. That means hormonal changes across the cycle and through menopause can influence how the system functions.
Do women need different doses of medical cannabis?
Research on sex differences in response is genuinely mixed. Some studies suggest women may experience comparable effects at lower doses; others find the differences are dose-dependent and inconsistent. There is no reliable “women’s dose” — which is why dosing should always be individualised with a practitioner.
Can medical cannabis replace hormone therapy?
No. They work through completely different mechanisms, and cannabis should not be considered a substitute for hormone therapy. If you are weighing your options, that is a discussion for your prescribing practitioner.
Is medical cannabis safe during pregnancy or breastfeeding?
Canadian obstetric guidance advises avoiding cannabis during pregnancy and breastfeeding. This applies to CBD products as well as THC.
How do I start the process?
Begin with a consultation. You can apply online or contact our team to discuss whether medical cannabis is appropriate for your situation.
Next step
If any of this is familiar — symptoms that shift with your cycle, or that arrived alongside perimenopause, and that have not responded to what you have already tried — it is worth a conversation with a practitioner who takes it seriously. Apply now or browse our resources.